Algorae taps AI to develop anti-cancer drug combos

Algorae Pharmaceuticals is now in discussions with Australian-based laboratories to start the precursor studies of the new drug combinations.

Algorae Pharmaceuticals executive chairman David Hainsworth said: This significant expansion highlights the important competitive advantage of AI to…